Since lipid metabolism disorder is the core part of hyperlipidemia, we focused on the three pathways closely associated with lipid metabolism, including PPAR signaling pathway, SREBP control of lipid synthesis pathway, and nuclear receptors in lipid metabolism and toxicity pathway (Table 4). This evidence concerns the gene PPARA and hyperlipidemia.